title: Ciprofloxacin plus fluocinolone acetonide versus ciprofloxacin alone in the treatment of diffuse otitis externa.
abstract: OBJECTIVE
  We aimed to evaluate the clinical efficacy of ciprofloxacin plus fluocinolone acetonide (antibiotic plus corticosteroid) ear drops compared to ciprofloxacin (antibiotic) ear drops in diffuse otitis externa.
  
  
  METHODS
  This was a multicentre, randomised, parallel-group, double-blind study involving 590 patients of both sexes aged 7 years or older.
  
  
  RESULTS
  The rate of clinical cure was higher (p = 0.01) with ciprofloxacin plus fluocinolone acetonide than with ciprofloxacin alone. The mean total symptom score was lower with ciprofloxacin plus fluocinolone acetonide (p = 0.005). No differences were found in the percentage of patients reporting resolution of otalgia between patients receiving ciprofloxacin plus fluocinolone acetonide and patients receiving only ciprofloxacin. Resolution of oedema and otorrhoea (p = 0.003 and p = 0.002, respectively) was higher with ciprofloxacin plus fluocinolone acetonide, as was eradication or presumed eradication (p = 0.003). There were eight mild adverse events, three with the ciprofloxacin plus fluocinolone acetonide combination (not related to the treatment) and five when ciprofloxacin was administered alone (directly related to the treatment).
  
  
  CONCLUSIONS
  Ciprofloxacin plus fluocinolone acetonide is a more effective treatment for diffuse otitis externa than ciprofloxacin alone. The ciprofloxacin plus fluocinolone acetonide combination also has an excellent safety profile.
authors.affiliation: Servicio de Otorrinolaringología (ORL), Hospital Vall d'Hebron,Barcelona,Spain.
authors.forename: J
authors.initials: J
authors.lastname: Lorente
authors.affiliation: Servicio ORL, Hospital Clínic i Provincial,Barcelona,Spain.
authors.forename: F
authors.initials: F
authors.lastname: Sabater
authors.affiliation: Servicio ORL, Hospital de Viladecans,Spain.
authors.forename: M P
authors.initials: MP
authors.lastname: Rivas
authors.affiliation: CAP Poble Nou,Barcelona,Spain.
authors.forename: J
authors.initials: J
authors.lastname: Fuste
authors.affiliation: Servicio ORL, Hospital Universitari Juan XXIII,Tarragona,Spain.
authors.forename: J
authors.initials: J
authors.lastname: Risco
authors.affiliation: Servicio ORL, Hospital de Poniente,El Ejido,Almería,Spain.
authors.forename: M
authors.initials: M
authors.lastname: Gómez
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002648:Child; D002939:Ciprofloxacin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010032:Otitis Externa / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D005446:Fluocinolone Acetonide; D002939:Ciprofloxacin